Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y 12 Antagonist

A new role for the A2b adenosine receptor in regulating platelet function

(2010) D. YANG et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antiplatelet therapies for the treatment of cardiovascular disease

(2010) Alan D. Michelson   NATURE REVIEWS DRUG DISCOVERY

The role of prostanoid receptors in mediating the effects of PGE2on human platelet function

(2010) David Iyú et al.   PLATELETS

Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke

(2010) Philip M.W. Bath et al.   STROKE

Mode of action of P2Y12 antagonists as inhibitors of platelet function

(2010) D. Iyú et al.   THROMBOSIS AND HAEMOSTASIS

Platelet P2Y12 receptor antagonist pharmacokinetics and pharmaco -dynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapies

(2010) Richard Becker et al.   THROMBOSIS AND HAEMOSTASIS

New P2Y12blockers

(2009) M. CATTANEO   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis

(2008) J. R. Glenn et al.   PLATELETS

A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility

(2008) Nikola Sprigg et al.   PLoS One

P2 receptors, platelet function and pharmacological implications

(2008) Christian Gachet   THROMBOSIS AND HAEMOSTASIS

Dipyridamole, cerebrovascular disease, and the vasculature

(2008) Subrata Chakrabarti et al.   VASCULAR PHARMACOLOGY

Gene expression profiling for the identification of G-protein coupled receptors in human platelets

(2007) Stefan Amisten et al.   THROMBOSIS RESEARCH